“Melanoma is the deadliest form of skin cancer. As such, new treatments for the disease are in strong demand. Norwegian […]
Other News |
Press Releases
Article in HealthTalk covering the Topline Results from Phase I Combination Trial Evaluating Universal Cancer Vaccine, UV1, in Malignant Melanoma Patients
“Ultimovacs med lovende overlevelsesdata på pasienter med føflekkreft som fikk kreftvaksinen UV1 i kombinasjon med immunterapi Ultimovacs har nå gått […]
BioStock has published an in-depth article on Ultimovacs
“Cancer’s heavy burden on society has created a strong demand for new innovative therapeutic solutions. Over the last decade, immunotherapy […]
Article in Asbestos.com on the NIPU trial
Asbestos.com this week published an article about the NIPU trial in which Ultimovacs’ universal cancer vaccine UV1 will be investigated in […]